Scarica l'app Stockscreener
14.81
1.40%
-0.21
Dopo l'orario di chiusura:
14.84
0.03
+0.20%
Precedente Chiudi:
$15.02
Aprire:
$14.78
Volume 24 ore:
105.12K
Relative Volume:
0.29
Capitalizzazione di mercato:
$918.66M
Reddito:
-
Utile/perdita netta:
$-48.26M
Rapporto P/E:
-18.75
EPS:
-0.7899
Flusso di cassa netto:
$-45.04M
1 W Prestazione:
-4.57%
1M Prestazione:
-6.27%
6M Prestazione:
+11.10%
1 anno Prestazione:
+24.87%
Intervallo 1D:
$14.56
$15.14
Intervallo di 1 settimana:
$14.56
$15.93
Portata 52W:
$7.98
$19.51
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.81 | 931.68M | 0 | -48.26M | -45.04M | -0.7899 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
Behavioral Patterns of GHRS and Institutional Flows - Stock Traders Daily
Buyout Rumor: Can GH Research PLC ride the EV wave2026 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn
Growth Value: Can Embrace Change Acquisition Corp Equity Right maintain sales growthMarket Sentiment Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
GH Research PLC (NASDAQ:GHRS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat - TipRanks
GH Research PLC (NASDAQ: GHRS) to join fireside chat at Stifel 2026 Virtual CNS Forum - Stock Titan
HighVista Strategies LLC Grows Stake in GH Research PLC $GHRS - MarketBeat
Analysts Set Expectations for GH Research Q1 Earnings - MarketBeat
Whale Trades: Is GH Research PLC stock undervalued right nowGap Up & Safe Swing Trade Setup Alerts - baoquankhu1.vn
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 - Seeking Alpha
Guggenheim raises GH Research stock price target to $34 on trial data - Investing.com Australia
Guggenheim raises GH Research stock price target to $34 on trial data By Investing.com - Investing.com India
GH Research reports Phase 2b trial results for depression treatment - Investing.com Nigeria
Activity Recap: Does GH Research PLC stock benefit from AI growthQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
(GHRS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Aug Ideas: Can GH Research PLC ride the EV waveJuly 2025 Closing Moves & Weekly Market Pulse Updates - baoquankhu1.vn
HC Wainwright Forecasts Reduced Earnings for GH Research - Defense World
Citizens raises GH Research stock price target on phase 3 progress - Investing.com India
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
Needham raises GH Research stock price target to $32 on phase 3 plans - Investing.com Australia
Needham raises GH Research stock price target to $32 on phase 3 plans By Investing.com - Investing.com South Africa
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
GH Research PLC Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
GH Research (NASDAQ:GHRS) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
FY2025 EPS Estimates for GH Research Cut by HC Wainwright - MarketBeat
GH Research Posts 2025 Results as TRD Drug GH001 Clears Key Phase 2b Milestone - TipRanks
GH Research Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times
GH Research reports Phase 2b trial results for depression treatment By Investing.com - Investing.com UK
GH Research (Nasdaq: GHRS) posts 2025 loss, touts strong Phase 2b TRD data - Stock Titan
Brokers Offer Predictions for GH Research FY2030 Earnings - Defense World
Analysts Issue Forecasts for GH Research FY2030 Earnings - MarketBeat
Entry Recap: Is GH Research PLC stock undervalued right now2025 Stock Rankings & Daily Profit Focused Stock Screening - baoquankhu1.vn
GH Research (NASDAQ:GHRS) Price Target Raised to $70.00 at HC Wainwright - MarketBeat
How (GHRS) Movements Inform Risk Allocation Models - Stock Traders Daily
Aug Outlook: Should you buy the dip on HTLM2025 Trading Recap & Verified Entry Point Signals - baoquankhu1.vn
Surprises Report: Is GH Research PLC showing insider buyingJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
GH Research PLC (NASDAQ:GHRS) Receives $34.11 Consensus Price Target from Brokerages - Defense World
GHRSGh Research Plc Latest Stock News & Market Updates - Stock Titan
Is GH Research PLC (1KA) stock at risk of policy regulationJuly 2025 Analyst Calls & Weekly High Conviction Ideas - mfd.ru
GH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CenterBook Partners LP Invests $2.38 Million in GH Research PLC $GHRS - MarketBeat
Stock Report: Is DBRG stock trending bullishJuly 2025 Analyst Calls & Consistent Profit Alerts - baoquankhu1.vn
GH Research (GHRS) Projected to Post Earnings on Thursday - MarketBeat
RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium - Finviz
RBC Capital Cite GH Research PLC’s (GHRS) Long-Term Sales Potential Following Psychedelics Symposium - Insider Monkey
GH Research PLC Reports Q3 2025 Financial Results - MSN
GH Research (NASDAQ:GHRS) Shares Up 8.8%Should You Buy? - MarketBeat
Trading Systems Reacting to (GHRS) Volatility - Stock Traders Daily
Is GH Research PLC stock forming a cup and handleJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - mfd.ru
GH Research PLC (GHRS) Stock Analysis: Potential Upside of 124.74% and Strong Buy Ratings - DirectorsTalk Interviews
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):